Research Article: Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer in China
Introduction:
Lung cancer stands as the predominant cause of cancer-related deaths across globe, giving rise to an estimated . million new cases and . million deaths annually. , Non-small cell lung cancer (NSCLC) constituted nearly % of all lung cancer cases, with squamous cell carcinoma representing a subtype associated with a comparatively diminished long-term survival rate, encompassing almost % of NSCLC occurrences. , Patients with squamous NSCLC face considerable challenges in deriving benefits from targeted therapy…
Read more